Hepatitis B and C infections among Japanese dental health workers: Insights from vaccination rates and screening results in the Oita prefecture
Clinical and Experimental Dental Research · 2024-04 · 10 (2)
DOI: 10.1002/cre2.871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dental Research, online erschienen am 20.03.2024. Verfasst von Yumiko Nagao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Graduate School of Medicine, Juntendo University, Tokyo, Japan. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis C. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objective
This study examined the hepatitis B virus (HBV) and hepatitis C virus (HCV) infection rates and vaccination rates for hepatitis B (HB) among dental healthcare workers (DHCWs) in the Oita prefecture, Japan.
Methods
Hepatitis virus testing was conducted on 1920 participants (486 dentists and 1434 dental staff). Anonymous data on age, gender, occupation, hepatitis B surface antigen (HBsAg), antibodies to hepatitis B surface antigen (anti‐HBs), antibodies to HCV (anti‐HCV), history of HB vaccination, and antiviral treatment for individuals with positive anti‐HCV were collected.
Results
The positivity rates for HBsAg, anti‐HBs, and anti‐HCV were 0.5%, 39.7%, and 0.6%, respectively. Dentists had significantly higher rates of anti‐HBs positivity (53.9% vs. 34.9%; p < .0001) and anti‐HCV positivity (1.4% vs. 0.3%; p = .0080) compared to dental staff. The vaccination and non‐vaccination rates among 1395 with a known HB vaccination history were 59.1% and 40.9%, respectively. Dentists had a significantly higher HB vaccine vaccination rate than the dental staff (73.6% vs. 54.0%; p < .0001). Those in the vaccination group were younger ( p < .0001), had a higher proportion of males ( p = .0022) and dentists ( p < .0001), a lower HBsAg positivity rate ( p < .0097), and a higher anti‐HBs positivity rate ( p < .0001) compared to those in the non‐vaccination group. The positivity rate of HBsAg and anti‐HBs in the unvaccinated group increased with age, with HBsAg positivity reaching 3.8% in the 70s and anti‐HBs positivity reaching 40.4% in the 70s and 66.7% in the 80s.
Conclusions
This study highlights the need to raise awareness about hepatitis prevention vaccination, particularly among dental staff, due to differences in HB vaccination rates across occupations. In particular, they indicated that elderly DHCWs may be more vulnerable to HBV infection. Regular monitoring of the vaccination rate and infection risk is crucial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
- Liver Center, Saga University Hospital, Saga, Japan.
- Oita Dental Association, Oita, Japan.
ORCID-Profile: Yumiko Nagao
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Nagao, Y., Kimura, T., Tomooka, K., & Wakita, H. (2024). Hepatitis B and C infections among Japanese dental health workers: Insights from vaccination rates and screening results in the Oita prefecture. Clinical and Experimental Dental Research, 10(2). https://doi.org/10.1002/cre2.871
Vancouver
Nagao Y, Kimura T, Tomooka K, Wakita H. Hepatitis B and C infections among Japanese dental health workers: Insights from vaccination rates and screening results in the Oita prefecture. Clinical and Experimental Dental Research. 2024;10(2). doi:10.1002/cre2.871
BibTeX
@article{Nagao2024,
author = {Nagao, Yumiko and Kimura, Tetsuya and Tomooka, Kiyohide and Wakita, Haruhiko},
title = {Hepatitis B and C infections among Japanese dental health workers: Insights from vaccination rates and screening results in the Oita prefecture},
journal = {Clinical and Experimental Dental Research},
year = {2024},
volume = {10},
number = {2},
doi = {10.1002/cre2.871}
}
EUVIMED